Does DABIGATRAN ETEXILATE Cause Transfusion? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Transfusion have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.1% of all adverse event reports for DABIGATRAN ETEXILATE.
17
Reports of Transfusion with DABIGATRAN ETEXILATE
0.1%
of all DABIGATRAN ETEXILATE reports
4
Deaths
13
Hospitalizations
How Dangerous Is Transfusion From DABIGATRAN ETEXILATE?
Of the 17 reports, 4 (23.5%) resulted in death, 13 (76.5%) required hospitalization, and 7 (41.2%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
Yes, Transfusion is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
ADALIMUMAB (264)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Transfusion Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB